Associated Papers
Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.
Yucer N et al.
Cell Reports, 2021
Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance.
Afghahi A et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2017
Absence of BRCA/FMR1 correlations in women with ovarian cancers.
Gleicher N et al.
Plos One, 2014
A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.
Hondow HL et al.
Bmc Cancer, 2011
21702907 (PubMed )
Supplement: 1471-2407-11-265-S5.XLS › Variants_in_targ._validation
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Zhang S et al.
Gynecologic Oncology, 2011
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA et al.
Journal of the National Cancer Institute, 2006
Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.
Judkins T et al.
Cancer Research, 2005
Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer.
Iau PT et al.
Breast Cancer Research and Treatment, 2004
Loss of heterozygosity in bilateral breast cancer.
Kollias J et al.
Breast Cancer Research and Treatment, 2000
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
Couch FJ et al.
The New England Journal of Medicine, 1997
BRCA1 mutation update and analysis.
Grade K et al.
Journal of Cancer Research and Clinical Oncology, 1996
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.
Friedman LS et al.
American Journal of Human Genetics, 1995
Select a paper to view details